Abeona Therapeutics (ABEO) Interest Income - Total (2021 - 2026)

Abeona Therapeutics' Interest Income - Total history runs 6 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• On a quarterly basis, Interest Income - Total rose 3.36% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $5.6 million, a 18.82% increase from a year earlier, with the FY2025 full-year figure at $5.6 million, up 30.85% from the prior year.
• Interest Income - Total eased to $1.4 million in Q1 2026 per ABEO's latest filing, from $1.5 million in the prior quarter.
• Across five years, Interest Income - Total topped out at $1.7 million in Q3 2025 and bottomed at $7000.0 in Q1 2022.
• The 5-year median for Interest Income - Total is $843000.0 (2024), against an average of $806529.4.
• Across the five-year window, Interest Income - Total surged 6460.0% in 2022 and decreased 13.77% in 2025, its largest moves.
• Year by year, Interest Income - Total stood at $328000.0 in 2022, then surged by 126.52% to $743000.0 in 2023, then surged by 37.69% to $1.0 million in 2024, then surged by 51.22% to $1.5 million in 2025, then decreased by 12.48% to $1.4 million in 2026.
• Per Business Quant, the three latest ABEO Interest Income - Total figures stand at $1.4 million (Q1 2026), $1.5 million (Q4 2025), and $1.7 million (Q3 2025).